Fifth Eye Inc. has raised $11.5 million in Series A funding led by Arboretum Ventures and Cultivation Capital. Other participants in the round included MINTS, the direct investing arm of the University of Michigan’s endowment, along with additional capital from previous investors Invest Michigan and 35 private angel investors.
MCIRCC’s objective is to transform critical care through innovation, integration, and entrepreneurship. But what does that mean and how is it being done? The MCIRCC Pre-Clinical Operative and Intensive Care Unit was created in February 2013 to embody this objective and has made great strides in high-risk, high-reward pursuits.
Dr. Hakam Tiba, Director of Pre-clinical Operative & Intensive Care Unit and Research Assistant Professor, sheds some light on the successes of the Ward & Tiba Critical Care Lab and how students and Twitter play an integral part.
A laboratory-created microscopic network of fibers helped researchers understand how white blood cells capture and even kill bacteria, offering insight into the effectiveness of antibiotics in the future.